Trader’s Buzzers: Mast Therapeutics, Inc. (NYSEMKT:MSTX), Envision Healthcare Holdings, Inc. (NYSE:EVHC)

99

Mast Therapeutics, Inc. (NYSEMKT:MSTX)

The company announced its last quarter financial performance results on 11/08/2016. Mast Therapeutics, Inc. (NYSEMKT:MSTX) belongs to Medical sector that declined -2.96% in value when last trading session closed at $0.08. The company has a market capitalization of $14.52 Million. The company’s stock has a Return on Assets (ROA) of -84.9 percent, a Return on Equity (ROE) of -219.8 percent and Return on Investment (ROI) of 0 percent. The company reached its 52-Week high of $0.71 on Sep 6, 2016 and 52-Week low of $0.07 on Nov 17, 2016.

Earnings per share (ttm) for Mast Therapeutics, Inc. (NYSEMKT:MSTX) according to Finviz Data is $-0.22.

This company was Downgrade by Maxim Group on 21-Sep-16  to Hold.

The 3 analysts offering 12-month price forecasts for Mast Therapeutics Inc have a median target of 2.50, with a high estimate of 5.00 and a low estimate of 2.00. The median estimate represents a +3,211.26% increase from the last price of 0.08.

Financial History for Mast Therapeutics, Inc. (NYSEMKT:MSTX):

Following Earnings result, share price were DOWN 3 times out of last 5 Qtrs. In the last 27 earnings reports, the company has topped earnings-per-share estimates 25% percent of times. It has met expectations  0 times and missed earnings  4  times.

The consensus recommendation for Mast Therapeutics, Inc. (NYSEMKT:MSTX) is 3. The rating scale runs from 1 to 5 with 5 indicating a Strong Sell, 1 indicating a Strong Buy and 3 indicating a Hold. The consensus recommendation 30 days ago for this company stood at 3. In comparison, the consensus recommendation 60 days ago was at 1, and 90 days ago was at 1 respectively.

Envision Healthcare Holdings, Inc. (NYSE:EVHC):

Envision Healthcare Holdings, Inc. (NYSE:EVHC) belongs to Medical sector closed its last session with a gain of 2.38 percent and closed its previous trading session at $22.76. According to Finviz reported data, the stock currently has Earnings per Share (EPS) (ttm) of $0.64. The company has the Market capitalization of $4.23 Billion. The company’s stock has a Return on Assets (ROA) of 1.9 percent, a Return on Equity (ROE) of 6.1 percent and Return on Investment (ROI) of 5.4 percent. The company reached its 52-Week high of $28.47 on Jun 9, 2016 and 52-Week low of $18.31 on Feb 9, 2016.

The growth estimate for Envision Healthcare Holdings, Inc. (NYSE:EVHC) for the current quarter is 20 percent. The projected growth estimate for the next quarter is 17.9 percent. The company’s stock has grown by 28.1 percent in the past 5 years. For the next 5 years, the company is expected to grow by 12.9 percent.

This company was Upgrade by Wells Fargo on 2-Nov-16 to Outperform.

The 12 analysts offering 12-month price forecasts for Envision Healthcare Holdings Inc have a median target of 29.00, with a high estimate of 32.00 and a low estimate of 25.00. The median estimate represents a +27.42% increase from the last price of 22.76.

Financial History for Envision Healthcare Holdings, Inc. (NYSE:EVHC):

Following Earnings result, share price were UP 7 times out of last 12 Qtrs. In the last 27 earnings reports, the company has topped earnings-per-share estimates 50% percent of times. It has met expectations  2  times and missed earnings  4  times.

The consensus recommendation for Envision Healthcare Holdings, Inc. (NYSE:EVHC) is 1.36. The rating scale runs from 1 to 5 with 5 indicating a Strong Sell, 1 indicating a Strong Buy and 3 indicating a Hold. The consensus recommendation 30 days ago for this company stood at 1.55. In comparison, the consensus recommendation 60 days ago was at 1.55, and 90 days ago was at 1.67 respectively.

Future Expectations for Envision Healthcare Holdings, Inc. (NYSE:EVHC):

When the current quarter ends, Wall Street expects Envision Healthcare Holdings, Inc. to have earnings per share of $0.42.

Revenue is expected to range from 1.61 Billion to 1.79 Billion with an average of 1.69 Billion.

-